Melatonin and Sleep Spindles in Autism

Purpose

Sleep disturbances and sensory sensitivities are common disabling features of autism, but their underlying causes are not clear. We hypothesize that both of these difficulties reflect disrupted communication between a deep brain structure, the thalamus, and the brain's outer layer, the cortex. This communication is mediated by the thalamic reticular nucleus (TRN). Due to its small size and location deep in the brain, we cannot assess TRN function without invasive techniques. Fortunately, sleep spindles, a specific brain rhythm provide a noninvasive read-out of TRN function. In Aim 1 we will examine whether reduced sleep spindles are related to worse sleep quality, impaired selective attention during wake, and sensory sensitivities in children with autism. In Aim 2, we will determine whether melatonin, which is commonly used to improve sleep, also increases sleep spindles in autism. If successful, this study will introduce TRN as a target for treatment of sleep disruption and guide larger home-based sleep studies.

Condition

  • Autism Spectrum Disorder

Eligibility

Eligible Ages
Between 12 Years and 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male and female subjects with ASD - 12-18 years of age - English speaking - Able to understand and respond to questionnaires in English

Exclusion Criteria

  • Pregnant or breastfeeding - Substance abuse or dependence within the past six months (nicotine abuse or dependence is not exclusionary) - Chronic medical conditions that affect sleep - Any unstable chronic medical condition such as asthma, diabetes, cystic fibrosis, or cardiac disease - History of head injury resulting in prolonged loss of consciousness or other neurological sequelae - IQ <70 - Other neurological disorder, including seizure disorder - Diagnosed sleep disorder - Known genetic causes of ASD - Currently taking melatonin or those who have had an adverse reaction to melatonin in the past

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Melatonin
5mg melatonin gummy 30 min before bedtime for 2 consecutive nights
  • Dietary Supplement: Melatonin
    5mg gummy 30 min before bedtime for 2 consecutive nights

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114
Contact:
Paige Townsend, PhD
617-702-2368
ptownsend2@mgh.harvard.edu

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Dara Manoach, PhD
617-724-6148
manoachlab@gmail.com